Athos accelerates the development of precision therapeutics for patients with immune-mediated diseases and cancer by scaling its autonomous AI analytical platform
Vultr, the world’s largest, privately-held cloud computing platform, announced that Athos Therapeutics, Inc., a clinical-stage biotechnology company, has chosen Vultr Cloud GPU to run its AI model training, tuning,...
Roche announced that its whole-slide imaging system, the Roche Digital Pathology Dx (VENTANA DP 200), has received 510(k) clearance from the United States Food and Drug Administration (FDA). The system is intended to aid the pathologist in reviewing and interpreting digital images of scanned pathology slides to help diagnose...
Certara, Inc., a global leader in model-informed drug development, unveiled its next-generation CoAuthor regulatory writing software. CoAuthor is an advanced writing platform designed for medical writers. It combines generative AI, document templates, Microsoft Word integration, and structured content authoring tools. CoAuthor accelerates the creation of regulatory documents while maintaining a...
At HLTH Europe, the Trustworthy & Responsible AI Network (TRAIN), a consortium of healthcare leaders, announced its expansion to Europe with the objective to help organizations in the region operationalize responsible AI through technology-based guardrails. Organizations that have come together to form the European TRAIN include Erasmus MC (the Netherlands), HUS Helsinki...
Cyrus Biotechnology, Inc., a Seattle-based software-enabled biotechnology firm, is spinning out a software and services group, Levitate Bio, to bring the Cyrus platform to the larger biopharma industry. This transition aligns with Cyrus’ advancement of its IdeS IgG degrading enzyme for multiple IgG-mediated autoimmune indications, as well as its...
EPAM Systems, Inc., a leading digital transformation services and product engineering company, announced its acquisition of Odysseus Data Services, Inc., a top health data analytics company. Odysseus will expand EPAM's ability to transform the life sciences value chain through advanced data analytics, data methods and artificial intelligence (AI).
"We are pleased...
QIAGEN announced the release of a new version of its clinical decision support software, QIAGEN Clinical Insight Interpret (QCI Interpret), that brings significant performance and scalability enhancements tailored for high-throughput, next-generation sequencing (NGS) labs moving to larger test panels and higher test volumes. The latest version of QCI Interpret...
Generative AI solutions address high-touch areas throughout the healthcare value chain to drive unified experiences and improve business outcomes for healthcare organizations.
As part of an expanded partnership announced last August, Cognizant has launched the first set of healthcare large language model (LLM) solutions on Google Cloud's generative AI (genAI) technology, including...
SOPHiA GENETICS, a cloud-native healthcare technology company and a leader in data-driven medicine, announced that Kepler Uniklinikum, Austria's second largest hospital, is live on SOPHiA GENETICS' platform. The hospital will use the SOPHiA DDM Platform to advance its next-generation sequencing (NGS) testing and diagnostics of blood-related cancers.
Kepler Uniklinikum, which...
Medical imaging AI company receives approval for algorithm enabling opportunistic detection and triage of vertebral compression fractures.
Avicenna.AI, a leading medical imaging AI company, has received 510(k) clearance from the US Food and Drug Administration (FDA) for CINA-VCF, a triage and notification AI tool that detects unsuspected vertebral compression fractures...
